Related Experiment Video
Updated: Jun 13, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Relation of platelet count to bleeding and vascular complications in patients undergoing coronary angiography
Param Vidwan1, Seonjoo Lee, Joseph S Rossi
1Division of Cardiology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC, USA.
Insights
Higher platelet counts increase the risk of bleeding and vascular complications in patients undergoing coronary angiography. This study found baseline platelet count to be a significant independent risk factor for these adverse events.
Area of Science:
- Cardiology
- Vascular Medicine
- Hematology
Background:
- Vascular and bleeding complications post-coronary angiography carry significant risks.
- Limited data exist on the association between platelet count and these complications.
Purpose of the Study:
- To investigate the relationship between baseline platelet count and the occurrence of bleeding or vascular complications in patients undergoing coronary angiography.
Main Methods:
- Retrospective cohort analysis of 3,466 adult patients undergoing coronary angiography.
- Data collected over a 2-year period at a single institution.
- Complications defined by American College of Cardiology CathPCI Registry criteria.
Main Results:
- A total of 143 complications (4.2%) were observed.
- The risk of complications significantly increased with higher platelet counts.
- Increasing platelet count, age, and percutaneous coronary intervention were independent predictors of complications.
Conclusions:
- Baseline platelet count is a strong and independent risk factor for bleeding and vascular complications in patients undergoing coronary angiography.
- Higher platelet levels necessitate careful consideration for risk stratification.
Abstract:
Vascular and bleeding complications are associated with significant morbidity and mortality, limited data are available on the relation between these complications and the platelet count in patients undergoing coronary angiography. We, therefore, performed a retrospective cohort analysis of 3,466 consecutive adults undergoing coronary angiography at a single institution during a 2-year period. The mean + or - SD age was 60 + or - 13 years; 58% of the patients were men, 67% were white, and 27% were black. The mean platelet count was 242 + or - 86 x 10(9)/L. A total of 143 bleeding or vascular complications (4.2%), as defined using the American College of Cardiology CathPCI Registry criteria, a part of the American College of Cardiology National Cardiovascular Disease Registry, occurred. The risk of complications increased with increasing platelet counts. Compared to the quartile with the lowest platelet counts, the odds ratio (OR) for complications was 1.41 for the second quartile (95% confidence interval 0.83 to 2.37, p = 0.20), 1.74 for the third quartile (95% confidence interval 1.04 to 2.93, p = 0.04), and 2.04 for the fourth quartile (95% confidence interval 1.21 to 3.44, p = 0.008). On multivariate logistic regression analysis, age, percutaneous coronary intervention, and increasing platelet counts were independent predictors of bleeding and vascular complications. When the analysis was limited to the 2,220 patients undergoing diagnostic coronary angiography without percutaneous coronary intervention, an increasing platelet quartile was a significant predictor of vascular and/or bleeding complications (OR 1.88, p = 0.08; OR 2.48, p = 0.01; OR 2.52, p = 0.01 for the second, third, and fourth quartiles, respectively). In conclusion, the baseline platelet count was a strong and independent risk factor for bleeding and vascular complications in patients undergoing coronary angiography.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Venous Thrombosis IV: Nursing Management
